Donald A. Bergstrom, President, R&D at Relay Therapeutics, Inc. (RLAY), sold 2,252 shares at $18.62 ($42K) on 2026-10-28, disclosed to the SEC on 2026-10-30.
Open-market sale of $42k RLAY by President, R&D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.